---

title: Clostridium Difficile Infection
authors:
    - Michelle Lin, MD
created: 2011/06/24
updates: null
categories:
    - Infectious Disease
---

# Clostridium Difficile Infection (CDI)

## Treatment

| Clinical Category                   | Presentation                                 | Treatment                                                                                                                                             |
| ----------------------------------- | -------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------- |
| 1st episode, mild-moderate severity |                                              | <span class="drug">Metronidazole</span> 500 mg PO TID x 10-14 days                                                                                    |
| 1st episode, severe                 | Serum WBC ≥15k or creatinine > 1.5x baseline | <span class="drug">Vancomycin</span> 125 mg PO QID x 10-14 days                                                                                       |
| 1st episode, severe,complicated     | Hypotension, shock ileus, or megacolon       | <span class="drug">Vancomycin</span> 500 mg QID PO/NG (PR if ileus) PLUS <span class="drug">Metronidazole</span> 500 mg IV q8h</span>                 |
| First recurrence                    |                                              | Same as for 1st episode (because minimal resistance)                                                                                                  |
| Second and more recurrences         |                                              | <span class="drug">Vancomycin</span> PO in tapered or pulsed regimen. Avoid <span class="drug">metronidazole</span> overuse because of neurotoxicity. |

## Background

**Definition of _Clostridium difficile_ infection (CDI)**

- Presence of diarrhea (3 unformed stools in ≤24 hours)
- Stool test positive for _C. difficile_ or its toxins, or colonoscopic findings of pseudomembranous colitis

**Epidemiology**

- Accounts for 20-30% of all antibiotic-associated diarrhea
- Most common cause of infectious diarrhea in healthcare settings

**Transmission**

- Fecal-oral route
- Median time from exposure to C. difficile to diarrhea symptoms = 2-3 days

**Risk factors to develop CDI**

- Age ≥ 65 years
- Duration of hospitalization
- Exposure to antibiotics (almost every Abx has been assoc with CDI – not just <span class="drug">clindamycin</span>)
  - 96% have received abx within 14 days before diarrhea onset 
- Cancer chemotherapy
- HIV
- GI surgery or manipulation of GI tract (i.e. tube feeding)

**Clinical presentation**

- Diarrhea may have mucous or occult blood

**Recurrence rates**

- 20% (typically within 4 weeks), despite <span class="drug">metronidazole</span> or <span class="drug">vancomycin</span> treatment ([Kelly et al., NEJM, 2008](https://www.ncbi.nlm.nih.gov/pubmed/?term=18971494))

## Complications

- Bowel perforation
- Dehydration
- Electrolyte imbalance 
- Hypoalbuminemia
- Hypotension
- Renal failure
- SIRS, sepsis
- Toxic megacolon
- Death

## References

- [Cohen SH, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by SHEA and IDSA. Infect Control Hosp Epidemiol. 2010; 31(5):431-55.](https://www.ncbi.nlm.nih.gov/pubmed/?term=20307191)
- [Kelly CP, LaMont JT.Clostridium difficile--more difficult than ever.N Engl J Med. 2008 Oct 30;359(18):1932-40. doi: 10.1056/NEJMra0707500.](https://www.ncbi.nlm.nih.gov/pubmed/?term=18971494)
